FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022302372> ?p ?o ?g. }

• W2022302372 endingPage "207" @default.
• W2022302372 startingPage "192" @default.
• W2022302372 abstract "Cytoglobin (CYGB) is ubiquitously expressed in the cytoplasm of fibroblastic cells in many organs, including hepatic stellate cells. As yet, there is no specific marker with which to distinguish stellate cells from myofibroblasts in the human liver. To investigate whether CYGB can be utilized to distinguish hepatic stellate cells from myofibroblasts in normal and fibrotic human liver, human liver tissues damaged by infection with hepatitis C virus (HCV) and at different stages of fibrosis were obtained by liver biopsy. Immunohistochemistry was performed on histological sections of liver tissues using antibodies against CYGB, cellular retinol-binding protein-1 (CRBP-1), α-smooth muscle actin (α-SMA), thymocyte differentiation antigen 1 (Thy-1), and fibulin-2 (FBLN2). CYGB- and CRBP-1-positive cells were counted around fibrotic portal tracts in histological sections of the samples. The expression of several of the proteins listed above was examined in cultured mouse stellate cells. Quiescent stellate cells, but not portal myofibroblasts, expressed both CYGB and CRBP-1 in normal livers. In fibrotic and cirrhotic livers, stellate cells expressed both CYGB and α-SMA, whereas myofibroblasts around the portal vein expressed α-SMA, Thy-1, and FBLN2, but not CYGB. Development of the fibrotic stage was positively correlated with increases in Sirius red-stained, α-SMA-positive, and Thy-1-positive areas, whereas the number of CYGB- and CRBP-1-positive cells decreased with fibrosis development. Primary cultured mouse stellate cells expressed cytoplasmic CYGB at day 1, whereas they began to express α-SMA at the cellular margins at day 4. Thy-1 was undetectable throughout the culture period. In human liver tissues, quiescent stellate cells are CYGB positive. When activated, they also become α-SMA positive; however, they are negative for Thy-1 and FBLN2. Thus, CYGB is a useful marker with which to distinguish stellate cells from portal myofibroblasts in the damaged human liver." @default.
• W2022302372 created "2016-06-24" @default.
• W2022302372 creator A5005826951 @default.
• W2022302372 creator A5019783291 @default.
• W2022302372 creator A5020091275 @default.
• W2022302372 creator A5024647870 @default.
• W2022302372 creator A5054249340 @default.
• W2022302372 creator A5057760694 @default.
• W2022302372 creator A5066914126 @default.
• W2022302372 creator A5067647579 @default.
• W2022302372 creator A5080913502 @default.
• W2022302372 creator A5081066622 @default.
• W2022302372 creator A5087434980 @default.
• W2022302372 creator A5090334203 @default.
• W2022302372 creator A5091645918 @default.
• W2022302372 date "2013-12-02" @default.
• W2022302372 modified "2023-10-11" @default.
• W2022302372 title "Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver" @default.
• W2022302372 cites W1553693482 @default.
• W2022302372 cites W1557168106 @default.
• W2022302372 cites W1599392598 @default.
• W2022302372 cites W1886141633 @default.
• W2022302372 cites W1967773801 @default.
• W2022302372 cites W1969133067 @default.
• W2022302372 cites W1972453204 @default.
• W2022302372 cites W1973427575 @default.
• W2022302372 cites W1973552842 @default.
• W2022302372 cites W1973974275 @default.
• W2022302372 cites W2000287530 @default.
• W2022302372 cites W2002965179 @default.
• W2022302372 cites W2006542398 @default.
• W2022302372 cites W2007141982 @default.
• W2022302372 cites W2014074632 @default.
• W2022302372 cites W2017697108 @default.
• W2022302372 cites W2017751529 @default.
• W2022302372 cites W2030861211 @default.
• W2022302372 cites W2031122915 @default.
• W2022302372 cites W2032228059 @default.
• W2022302372 cites W2040617968 @default.
• W2022302372 cites W2046755222 @default.
• W2022302372 cites W2051696368 @default.
• W2022302372 cites W2054686093 @default.
• W2022302372 cites W2058235113 @default.
• W2022302372 cites W2064675301 @default.
• W2022302372 cites W2065757450 @default.
• W2022302372 cites W2072115406 @default.
• W2022302372 cites W2072438363 @default.
• W2022302372 cites W2076492703 @default.
• W2022302372 cites W2082579037 @default.
• W2022302372 cites W2085061406 @default.
• W2022302372 cites W2087688111 @default.
• W2022302372 cites W2094410857 @default.
• W2022302372 cites W2099711702 @default.
• W2022302372 cites W2105469517 @default.
• W2022302372 cites W2109083944 @default.
• W2022302372 cites W2111288662 @default.
• W2022302372 cites W2131993525 @default.
• W2022302372 cites W2146324297 @default.
• W2022302372 cites W2165062244 @default.
• W2022302372 cites W2179353943 @default.
• W2022302372 cites W2408084628 @default.
• W2022302372 doi "https://doi.org/10.1038/labinvest.2013.135" @default.
• W2022302372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24296877" @default.
• W2022302372 hasPublicationYear "2013" @default.
• W2022302372 type Work @default.
• W2022302372 sameAs 2022302372 @default.
• W2022302372 citedByCount "48" @default.
• W2022302372 countsByYear W20223023722014 @default.
• W2022302372 countsByYear W20223023722015 @default.
• W2022302372 countsByYear W20223023722016 @default.
• W2022302372 countsByYear W20223023722017 @default.
• W2022302372 countsByYear W20223023722018 @default.
• W2022302372 countsByYear W20223023722019 @default.
• W2022302372 countsByYear W20223023722020 @default.
• W2022302372 countsByYear W20223023722021 @default.
• W2022302372 countsByYear W20223023722022 @default.
• W2022302372 countsByYear W20223023722023 @default.
• W2022302372 crossrefType "journal-article" @default.
• W2022302372 hasAuthorship W2022302372A5005826951 @default.
• W2022302372 hasAuthorship W2022302372A5019783291 @default.
• W2022302372 hasAuthorship W2022302372A5020091275 @default.
• W2022302372 hasAuthorship W2022302372A5024647870 @default.
• W2022302372 hasAuthorship W2022302372A5054249340 @default.
• W2022302372 hasAuthorship W2022302372A5057760694 @default.
• W2022302372 hasAuthorship W2022302372A5066914126 @default.
• W2022302372 hasAuthorship W2022302372A5067647579 @default.
• W2022302372 hasAuthorship W2022302372A5080913502 @default.
• W2022302372 hasAuthorship W2022302372A5081066622 @default.
• W2022302372 hasAuthorship W2022302372A5087434980 @default.
• W2022302372 hasAuthorship W2022302372A5090334203 @default.
• W2022302372 hasAuthorship W2022302372A5091645918 @default.
• W2022302372 hasBestOaLocation W20223023721 @default.
• W2022302372 hasConcept C134018914 @default.
• W2022302372 hasConcept C142724271 @default.
• W2022302372 hasConcept C176891718 @default.
• W2022302372 hasConcept C195521686 @default.
• W2022302372 hasConcept C204232928 @default.
• W2022302372 hasConcept C207865475 @default.

• next